Probiotic supplements are often consumed after antibiotic treatment to prevent antibiotic-associated diarrheal disease, most ...

The antibiotic vancomycin, ... Treatment for deadly superbug C. diff may be weakening. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 04 / 240425131603.htm.

Any patient who was diagnosed with a C. diff infection within 30 days of antibiotic treatment was presumed to have antibiotic-associated C. diff. About 87% of patients were treated with ...

All probiotics are not created equal, according to new research from North Carolina State University. In a mouse model, researchers found that ...

Current guidelines recommend using either metronidazole or vancomycin to treat C. diff infections. “For many years the two antibiotics were considered to be equivalent in their ability to cure C ...

Researchers have identified two distinct mechanisms of drug resistance in C. difficile, but its ability to withstand antibiotics comes with downsides for the bacteria.

University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides difficile (C. diff) among adults given low-dose oral vancomycin during ...

Researchers from New York City-based Montefiore Medical Center and New York City-based Yeshiva University’s Albert Einstein College of Medicine treated C. diff patients with either high or low ...

PnimB G-associated metronidazole (MTZ) resistance co-occurs with fluroquinolone resistance and pandemic spread. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-39429-x Researchers at ...

The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research ...

SALT LAKE CITY – Over the past two decades there has been a sharp rise in the number and severity of infections caused by the bacteria Clostridium difficile often shortened to C. diff now the most ...

A new study on Clostridioides difficile infections finds that choosing an alternative antibiotic for high-risk patients with pneumonia can reduce infection risk. C. diff infections can be deadly ...